Sermorelin is a synthetic 29–amino acid peptide analog of growth hormone–releasing hormone (GHRH), designed to stimulate pituitary somatotrophs in non-human test subjects. Research in non-human models has highlighted its usefulness for exploring metabolic regulation, cellular proliferation, and endocrine feedback mechanisms. Its rapid pharmacokinetics and receptor specificity make Sermorelin a valuable tool for investigating GH-mediated processes—such as tissue regeneration and anabolic pathways—within controlled laboratory environments.

